FAST Act Modernization and Simplification of Regulation S-K Correction

13796 Federal Register / Vol. 84, No. 67 / Monday, April 8, 2019 / Rules and Regulations 1Though DEA has used the term ‘‘final order’’ with respect to temporary scheduling orders in the past, this notice adheres to the statutory language of 21 U.S.C. 811(h), which refers to a ‘‘temporary than an assessment every two years) due to concerns not meeting several VWP requirements. In 2016, DHS extended Greece’s VWP designation on a provisional basis through March 31, 2017, to address concerns over migrant vetting, information-sharing gaps, and passport-issuance practices. Additionally, DHS reduced Greece’s ESTA validity period from two years to one year and committed Greece to implement five lines of effort specified in a Joint Statement in order to remove Greece from a provisional VWP status. In 2017, DHS sent correspondence to Greece defining a set of actions that would justify ESTA normalization. Greece has made successful progress in all five lines of effort and has completed all of the elements required for ESTA normalization that had been communicated in 2017. Greece has enacted necessary legislation to authorize issuance and replacement of national identification cards (biometric chip), expanded systematic refugee vetting at all migrant processing centers, and enacted Passenger Name Recognition (PNR) legislation to implement the EU PNR Directive. For these reasons, DHS is publishing this document announcing that it is increasing Greece’s ESTA validity period to two years. Claire Grady, Senior Official Performing the Duties of the Deputy Secretary, Department of Homeland Security. [FR Doc. 2019–06750 Filed 4–5–19; 8:45 am] BILLING CODE P SECURITIES AND EXCHANGE COMMISSION 17 CFR Parts 229, 230, 232, 239, 240, 249, 270, 274, and 275 [Release No. 33–10618; 34–85381; IA–5206; IC–33426; File No. S7–08–17] RIN 3235–AM00 FAST Act Modernization and Simplification of Regulation S–K Correction In rule document 2019–05695, appearing on pages 12674 through 12738, in the issue of Tuesday, April 2, 2019, make the following corrections:

1. On page 12675, in the table, in the second column, in the tenth line from the top of the page, the text entry that reads ‘‘§ 249.218’’ should read ‘‘§ 249.220f’’. PART 249—FORMS, SECURITIES EXCHANGE ACT OF 1934 [Corrected] ■ 2. On page 12729, in the second column, five asterisks (* * * * *) indicating the existence of text not listed and unchanged should appear above the text reading ‘‘INSTRUCTIONS AS TO EXHIBITS’’. [FR Doc. C1–2019–05695 Filed 4–5–19; 8:45 am] BILLING CODE 1301–00–D DEPARTMENT OF JUSTICE Drug Enforcement Administration 21 CFR Part 1308 [Docket No. DEA–446] Schedules of Controlled Substances: Extension of Temporary Placement of 5F–ADB, 5F–AMB, 5F–APINACA, ADB– FUBINACA, MDMB–CHMICA and MDMB–FUBINACA in Schedule I of the Controlled Substances Act AGENCY: Drug Enforcement Administration, Department of Justice. ACTION: Temporary rule; temporary scheduling order; extension. SUMMARY: The Acting Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to extend the temporary schedule I status of six synthetic cannabinoids (SC). The substances are: methyl 2-(1-(5- fluoropentyl)-1H-indazole-3- carboxamido)-3,3-dimethylbutanoate [5F–ADB; 5F–MDMB–PINACA]; methyl 2-(1-(5-fluoropentyl)-1H-indazole-3- carboxamido)-3-methylbutanoate [5F– AMB]; N-(adamantan-1-yl)-1-(5- fluoropentyl)-1H-indazole-3- carboxamide [5F–APINACA, 5F– AKB48]; N-(1-amino-3,3-dimethyl-1- oxobutan-2-yl)-1-(4-fluorobenzyl)-1H￾indazole-3-carboxamide [ADB– FUBINACA]; methyl 2-(1- (cyclohexylmethyl)-1H-indole-3- carboxamido)-3,3-dimethylbutanoate [MDMB–CHMICA, MMB–CHMINACA] and methyl 2-(1-(4-fluorobenzyl)-1H￾indazole-3-carboxamido)-3,3- dimethylbutanoate [MDMB– FUBINACA], including their optical, positional and geometric isomers, salts, and salts of isomers. The schedule I status of 5F–ADB, 5F–AMB, 5F– APINACA, ADB–FUBINACA, MDMB– CHMICA and MDMB–FUBINACA will expire on April 10, 2019. This temporary order will extend the temporary scheduling of 5F–ADB, 5F– AMB, 5F–APINACA, ADB–FUBINACA, MDMB–CHMICA and MDMB– FUBINACA for one year or until the permanent scheduling action for these six substances is completed, whichever occurs first. DATES: This temporary scheduling order, which extends the order (82 FR 17119, April 10, 2017), is effective April 10, 2019 and expires on April 10, 2020. If DEA publishes a final rule making this scheduling action permanent, this order will expire on the effective date of that rule, if the effective date is earlier than April 10, 2020. FOR FURTHER INFORMATION CONTACT: Lynnette M. Wingert, Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 598–6812. SUPPLEMENTARY INFORMATION: Background and Legal Authority On April 10, 2017, the Acting Administrator of the Drug Enforcement Administration (DEA) published an order in the Federal Register (82 FR

17119. temporarily placing methyl 2-(1- (5-fluoropentyl)-1H-indazole-3- carboxamido)-3,3-dimethylbutanoate [5F–ADB; 5F–MDMB–PINACA], methyl 2-(1-(5-fluoropentyl)-1H-indazole-3- carboxamido)-3-methylbutanoate [5F– AMB], N-(adamantan-1-yl)-1-(5- fluoropentyl)-1H-indazole-3- carboxamide [5F–APINACA, 5F– AKB48], N-(1-amino-3,3-dimethyl-1- oxobutan-2-yl)-1-(4-fluorobenzyl)-1H￾indazole-3-carboxamide [ADB– FUBINACA], methyl 2-(1- (cyclohexylmethyl)-1H-indole-3- carboxamido)-3,3-dimethylbutanoate [MDMB–CHMICA, MMB–CHMINACA] and methyl 2-(1-(4-fluorobenzyl)-1H￾indazole-3-carboxamido)-3,3- dimethylbutanoate [MDMB– FUBINACA], synthetic cannabinoid (SC) substances, in schedule I of the Controlled Substances Act (CSA) pursuant to the temporary scheduling provisions of 21 U.S.C. 811(h). That order was effective on the date of publication, and was based on findings by the Acting Administrator of the DEA that the temporary scheduling of these SCs was necessary to avoid an imminent hazard to the public safety pursuant to 21 U.S.C. 811(h)(1). Section 201(h)(2) of the CSA, 21 U.S.C. 811(h)(2), requires that the temporary control of these substances expires two years from the effective date of the scheduling order, or on April 10, 2019. However, the CSA also provides that during the pendency of proceedings under 21 U.S.C. 811(a)(1) with respect to the substance, the temporary scheduling 1 of that substance VerDate Sep<11>2014 15:49 Apr 05, 2019 Jkt 247001 PO 00000 Frm 00002 Fmt 4700 Sfmt 4700 E:\FR\FM\08APR1.SGM 08APR1 jbell on DSK30RV082PROD with RULES